Portfolio company
Sequins Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Sequins Bio develops synthetic DNA and RNA spike-in controls and bioinformatics tools for genomic sequencing laboratories to ensure data accuracy and workflow standardisation.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ArgenTAG
This company develops single-cell genomic sequencing kits and barcoding technology for researchers to analyse complex biological data using long-read sequencing platforms.
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
Wobble Genomics
This company develops full-length RNA sequencing technology for pharmaceutical and diagnostic organisations to improve biomarker discovery, patient stratification and clinical success rates.
Seqera
This company provides a bioinformatics platform for life sciences organisations to build, manage and scale data pipelines and scientific workflows.
Glyphic Bio
This company develops a single-molecule protein sequencing platform for researchers to identify amino acids and post-translational modifications in the human proteome.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Sequencing
The company provides DNA testing kits and a platform for genetic data storage and health analysis for individual consumers.
Seed, 2024
This company develops a single-molecule DNA sequencing platform for clinical diagnostics, agriculture, and biosecurity sectors.
